Dr. Gillian Black-Noller is Senior Director, Medical Affairs within the Cardiovascular and Metabolic Team at Pfizer. She graduated from the University of Sheffield Medical School in the UK and for the past 26 years has been working in the pharmaceutical industry. Her initial interest in this area came during medical school, where she took an additional year of training in pharmacology to explore how our understanding of biological systems could lead to drug discovery and development. Her subsequent early experiences in biotechnology and the larger traditional pharmaceutical companies allowed her to appreciate how to match patient needs to development programs.
In her career, she has led Pharmacovigilance (safety) teams and Clinical Development teams. She remains a passionate supporter of the education of health professionals around the process of drug discovery and development.